Key result
This review evaluates the safety and efficacy of a third-generation biolimus-eluting stent with biodegradable polymer compared to durable polymer stents based on the SORT OUT V and COMPARE II trials.
Why the study?
Does a third generation biolimus-eluting stent with biodegradable polymer improve safety and efficacy compared to durable polymer drug-eluting stents in patients receiving percutaneous coronary intervention?
Does a third generation biolimus-eluting stent with biodegradable polymer improve safety and efficacy compared to durable polymer drug-eluting stents in patients receiving percutaneous coronary intervention?
This review evaluates the SORT OUT V and COMPARE II trials to determine if biodegradable polymer biolimus-eluting stents reduce the risk of late stent thrombosis compared to durable polymer stents.
Answers are grounded in this paper and cite their sources.
Does not alter stent selection in PCI; leaves open whether biodegradable polymer biolimus-eluting stents reduce late thrombosis.
Evaluation of: Christiansen E, Jensen L, Thayssen P et al. Biolimus eluting biodegradable polymer coated stent vs durable polymer coated sirolimus eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomized non inferiority trial. Lancet 381, 661–669 (2013); Smits P, Hofma S, Togni M et al. Abluminal biodegradable polymer biolimus-eluting stent vs durable polymer everolimus eluting stent (COMPARE II): a randomized, controlled, non inferiority trial. Lancet 381, 651–660 (2013).Since their apparition, first generation drug-eluting stents (DESs) have raised concerns regarding the risk of late and very late stent thrombosis as compared to bare metal stents and require prolonged dual antiplatelet therapy. Aside from delayed strut endothelialisation, positive vessel remodelling and late stent mal-apposition due to chronic inflammation may be a leading cause for these stent thromboses. In fact, the persistence of the durable polymer after complete drug release is responsible for local hypersensitivity and inflammatory reactions. Third generation DESs with biocompatible or biodegradable polymer have subsequently been developed to address this issue. In this article, we evaluate and discuss the results of two recent publications investigating safety and efficacy of a third generation DES with biodegradable polymer as compared to first and second generation DESs with durable polymer.
No takes yet. Share an insight, caveat, or question.
Lemesle et al. (2013) conducted a review in Patients receiving percutaneous coronary intervention. Biolimus-eluting stent with biodegradable polymer vs. First and second generation drug-eluting stents with durable polymer was evaluated. This review evaluates the safety and efficacy of a third-generation biolimus-eluting stent with biodegradable polymer compared to durable polymer stents based on the SORT OUT V and COMPARE II trials.
Synapse has enriched 10 related papers. Consider them for comparative context: